Quick Summary:
Ignite your strategic decision-making with the cutting-edge insights revealed in our latest market research report on the advancing Drug Eluting Balloons (DEBs) industry. With an estimated growth to a sizeable US$3 Billion by 2030, the wealth of opportunities within this high-growth market is too significant to overlook. The report delineates key factors driving this rapid expansion, explores various market segments, including the promising Peripheral segment predicted to reach an impressive US$1.7 Billion, and provides comprehensive insight into the trajectory of the Coronary segment.
The report doesn’t stop at global assessments. It transcends to regional analysis, pinpointing the growth potential in different markets including the U.S, China, Japan, Canada, and Germany. Understand the dynamics and growth opportunities of the DEBs market across these diverse geographies. Furthermore, dive into the competitive landscape with a detailed profiling of 42 industry contenders such as Acrostak Int. Distr. Sarl, B. Braun Melsungen AG, Cook Medical, Inc. and Medtronic PLC, among others. This report is instrumental in providing a holistic view of the DEBs industry and will empower your business to make calculated, data-driven decisions.
Global Drug Eluting Balloons (DEBs) Market to Reach $3 Billion by 2030
The global market for Drug Eluting Balloons (DEBs) estimated at US$1.3 Billion in the year 2022, is projected to reach a revised size of US$3 Billion by 2030, growing at a CAGR of 11.4% over the analysis period 2022-2030. Peripheral, one of the segments analyzed in the report, is projected to record 9.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Coronary segment is readjusted to a revised 14.4% CAGR for the next 8-year period.The U.S. Market is Estimated at $385 Million, While China is Forecast to Grow at 11% CAGR
The Drug Eluting Balloons (DEBs) market in the U.S. is estimated at US$385 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$534.7 Million by the year 2030 trailing a CAGR of 11% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.6% and 9.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.Select Competitors (Total 42 Featured) -
- Acrostak Int. Distr. Sarl
- B. Braun Melsungen AG
- BARD, A Becton, Dickinson Company
- Cardionovum GmbH
- Cook Medical, Inc.
- Eurocor GmbH
- Medtronic PLC
- Spectranetics Corporation
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Drug Eluting Balloons (DEBs)?
What is the growth rate of the Global Market for Drug Eluting Balloons (DEBs)?
What is the forecasted size of the Global Market for Drug Eluting Balloons (DEBs)?
Who are the key companies in the Global Market for Drug Eluting Balloons (DEBs)?
Report Attribute | Details |
---|---|
No. of Pages | 194 |
Published | September 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 1.3 Billion |
Forecasted Market Value ( USD | $ 3 Billion |
Compound Annual Growth Rate | 11.0% |
Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Acrostak Int. Distr. Sarl
- B. Braun Melsungen AG
- BARD, A Becton, Dickinson Company
- Cardionovum GmbH
- Cook Medical, Inc.
- Eurocor GmbH
- Medtronic PLC
- Spectranetics Corporation